Financial Wealth Daily

Starlink emerges as fresh battleground between Musk, Brazil

By Ricardo Brito and Luciana Magalhaes BRASILIA/SAO PAULO (Reuters) -Tensions between Brazil and Elon Musk’s business empire ratcheted up further as the country’s telecoms regulator threatened to sanction his satellite broadband company Starlink hours after its top court stood behind a controversial decision to ban social network X from the country. Brazil’s President Luiz Inacio Lula da…

Read More

ByteDance taps banks for $9.5 billion Asia dollar corporate loan, sources say

(Reuters) – TikTok-owner ByteDance is tapping banks for a $9.5 billion loan that would be the biggest dollar-denominated corporate facility in Asia ex-Japan, two sources with knowledge of the matter said on Monday. Citigroup, Goldman Sachs and JPMorgan are the coordinators of the financing, which carries a tenor of three years and can be extended…

Read More

Trump ‘has a lot on his plate’, misunderstands Taiwan’s chip role, minister says

TAIPEI (Reuters) – Former U.S. President Donald Trump “has a lot on his plate” and misunderstands Taiwan’s role in the semiconductor industry, possibly because others have misinformed him, the island’s Economy Minister Kuo Jyh-huei said on Monday. Trump, the Republic nominee in November’s presidential election, unnerved democratically governed Taiwan, which is claimed by China, by…

Read More

Tech market values fall on AI costs and recession fears; Eli Lilly, Berkshire gain

(Reuters) – Market values of major tech firms declined in August amid concerns over escalating artificial intelligence infrastructure costs and rising recession risks that would make the stocks particularly vulnerable during a market correction. Last month, Alphabet Inc’s lost 4.7% of its market value as a slowdown in YouTube’s advertising sales fuelled concerns about its…

Read More

US FDA approves Emergent’s smallpox vaccine for people at high risk of mpox

(Reuters) -The U.S. Food and Drug Administration granted expanded approval to Emergent BioSolutions’ smallpox vaccine for use by people at high risk of mpox infection, sending the drugmaker’s shares surging 20% before the bell on Friday. The FDA clearance, announced late Thursday by the company, makes the vaccine, called ACAM2000, the second approved shot against…

Read More